Research Article Volume 22 Issue 5 - 2028

HRCT: A Tool to Curtail the Spread Rate of SARS-CoV-2 for Early and Authentic Triaging of COVID-19 Patients

Ayma Aftab1, Samia Afzal1*, Muhammad Idrees1, Aftab Ahmad2, Tabasum Naz2, Vivek Sharma3 and Liaqat Ali2*

1Division of Molecular Virology and Infectious Diseases, Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore,
Pakistan
2Department of Microbiology and Immunology, National University of Medical Sciences, Rawalpindi, Pakistan
3Department of Environmental Sciences, University of Freiburg, Freiburg, Germany

*Corresponding Author: Samia Afzal, Division of Molecular Virology and Infectious Diseases, Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan and Liaqat Ali, Department of Microbiology and Immunology, National University of Medical Sciences, Rawalpindi, Pakistan.
Received: March 16, 2026; Published: May 01, 2026



To explain the characteristics of chest high resolution computed tomography (HRCT) among COVID-19 suspected cases. To reveal the consistency of HRCT chest findings with real-time polymerase chain reaction diagnosis in order to analyze the sensitivity and reliability of these two methods for the detection of omicron. This will help in early triaging of positive patients from negative patients and will eventually reduce the spread rates. A comparative study conducted on Pakistani COVID-19 suspected patients during June, 2021 to December, 2021. 2494 suspected COVID-19 patients were included in the study who were tested using both RT-PCR and chest HRCT. Based on HRCT analysis, patients were categorized as “Confirmed COVID positive”, “Likely COVID positive” or “COVID negative” by radiologists. RT-PCR was selected as standard of reference to evaluate chest HRCT sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). 1114 patients were RT-PCR positive and 1380 were RT-PCR negative. 1164 (46.6%) were included in “Confirmed COVID positive”, 1277 (51.2%) in “COVID negative” and 53 (2.1%) in “Likely COVID positive” on the basis of HRCT. 87.70% sensitivity, 97.46% specificity, 96.54% PPV and 90.76% NPV were obtained by comparing “Confirmed COVID positive” with RT-PCR. Depending upon the obtained sensitivity, CT scan can be used as a reliable time efficient tool to diagnose COVID-19 suspected patients instead of only relying upon RT-PCR that is time intensive along with certain limitations. Moreover, some RT-PCR negative patients also showed remarkable changes in lungs physiology that confirms the coronavirus disease.

Keywords: False Negative; COVID-19; Real Time Polymerase Chain Reaction (RT-PCR); High Resolution Computed Tomography (HRCT)

  1. Armocida Benedetta., et al. “The Italian health system and the COVID-19 challenge”. The Lancet Public Health5 (2020): e253.
  2. Thakur Vikram and Radha Kanta Ratho. "OMICRON (B. 1.1. 529): a new SARS-CoV-2 variant of concern mounting worldwide fear”. Journal of Medical Virology5 (2022): 1821-1824.
  3. Shoaib Muhammad and Farooq Abdullah. "Risk reduction of COVID-19 pandemic in Pakistan”. Social Work in Public Health7 (2020): 557-568.
  4. Fan Yuqi., et al. “COVID-19 detection from X-ray images using multi-kernel-size spatial-channel attention network”. Pattern Recognition 119 (2021): 108055.
  5. Teymouri Manoucher., et al. “Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19”. Pathology-Research and Practice 221 (2021): 153443.
  6. Li Jingwen., et al. “Radiology indispensable for tracking COVID-19”. Diagnostic and Interventional Imaging2 (2021): 69-75.
  7. Soedarsono Soedarsono., et al. “Management of severe COVID-19 patient with negative RT-PCR for SARS-CoV-2: Role of clinical, radiological, and serological diagnosis”. Radiology Case Reports6 (2021): 1405-1409.
  8. Cozzi Diletta., et al. “Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome”. La Radiologia Medica8 (2020): 730-737.
  9. Bahreini Fatemeh., et al. “Reducing false negative PCR test for COVID-19”. International Journal of Maternal and Child Health and AIDS3 (2020): 408.
  10. Jindal Himanshu., et al. “False-negative RT-PCR findings and double mutant variant as factors of an overwhelming second wave of COVID-19 in India: an emerging global health disaster”. SN Comprehensive Clinical Medicine12 (2021): 2383-2388.
  11. Kashyape Rohan and Richa Jain. "The utility of HRCT in the initial diagnosis of COVID-19 pneumonia-An Indian perspective”. Indian Journal of Radiology and ImagingS1 (2021): S178-S181.
  12. Fang Yicheng., et al. “Sensitivity of chest CT for COVID-19: comparison to RT-PCR”. Radiology2 (2020): E115-E117.
  13. Kanne Jeffrey P. "Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist”. Radiology1 (2020): 16-17.
  14. Rahmani Amir Masoud and Seyedeh Yasaman Hosseini Mirmahaleh. "Coronavirus disease (COVID-19) prevention and treatment methods and effective parameters: A systematic literature review”. Sustainable Cities and Society 64 (2021): 102568.
  15. Abbasi Hina Hafeez., et al. “Role of HRCT for rapid triage of patients with covid-19 pneumonia”. Journal of Rawalpindi Medical College 1 (2021).
  16. Roy Chayan., et al. “Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus”. Genomics 6 (2020): 5331-5342.
  17. Zhang Li., et al. “The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron”. Emerging Microbes and Infections1 (2022): 1-5.
  18. Rana Muhammad Suleman., et al. “Novel coronavirus outbreak in Pakistan: Beware of dengue”. Journal of the Formosan Medical Association1 (2020): 765-766.
  19. Mohapatra Ranjan K., et al. “Omicron (B. 1.1. 529 variant of SARS-CoV-2); an emerging threat: current global scenario”. Journal of Medical Virology5 (2022): 1780-1783.
  20. Kumar Suresh., et al. “Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein”. Journal of Medical Virology4 (2022): 1641-1649.
  21. Hanif Nadia., et al. “Comparison of HRCT chest and RT-PCR in diagnosis of COVID-19”. Journal of College of Physicians and Surgeons Pakistan 1 (2021): S1-S6.
  22. Murtaza Hafiz G.., et al. “Comparison of high-resolution computed tomography and real-time reverse transcriptase polymerase chain reaction in diagnosis of covid-19 pneumonia in intensive care unit population”. Cureus2 (2021): e13602.
  23. Xie Xingzhi., et al. “Chest CT for typical coronavirus disease 2019 (COVID-19) pneumonia: relationship to negative RT-PCR testing”. Radiology2 (2020): E41-E45.
  24. Kovács Anita., et al. “The sensitivity and specificity of chest CT in the diagnosis of COVID-19”. European Radiology5 (2021): 2819-2824.
  25. Carotti Marina., et al. “Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists”. La Radiologia Medica7 (2020): 636-646.
  26. Li Mingzhi., et al. “Coronavirus disease (COVID-19): spectrum of CT findings and temporal progression of the disease”. Academic Radiology5 (2020): 603-608.
  27. Stockdale Alexander J., et al. “Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR”. The Journal of Infection 6 (2021): 260-268.
  28. Valenzuela Fernández Agustín., et al. “Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection”. International Journal of Infectious Diseases 99 (2020): 190-192.
  29. Freire-Paspuel Byron., et al. “Analytical sensitivity and clinical performance of" COVID-19 RT-PCR Real TM FAST (CY5) (ATGen, Uruguay) and" ECUGEN SARS-CoV-2 RT-qPCR"(UDLA-STARNEWCORP, Ecuador)": High quality-low cost local SARS-CoV-2 tests for South America”. PLoS Neglected Tropical Diseases4 (2022): e0010082.
  30. Verna Roberto., et al. “Analytical performance of COVID-19 detection methods (RT-PCR): scientific and societal concerns”. Life7 (2021):660.

Samia Afzal and Liaqat Ali., et al. “HRCT: A Tool to Curtail the Spread Rate of SARS-CoV-2 for Early and Authentic Triaging of COVID-19 Patients”. EC Microbiology 22.5 (2026): 01-07.